Polycystic ovary syndrome

AE Joham, RJ Norman, E Stener-Victorin… - The lancet Diabetes & …, 2022 - thelancet.com
Polycystic ovary syndrome (PCOS) affects 5–18% of women, and is a reproductive,
metabolic, and psychological condition with impacts across the lifespan. The cause is …

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

Polycystic ovary syndrome

R Azziz, E Carmina, ZJ Chen, A Dunaif… - Nature reviews Disease …, 2016 - nature.com
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …

Update on PCOS: consequences, challenges, and guiding treatment

KM Hoeger, A Dokras, T Piltonen - The Journal of Clinical …, 2021 - academic.oup.com
Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine
disorders in women and despite this, diagnostic challenges, delayed diagnosis, and less …

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

RS Legro, SA Arslanian, DA Ehrmann… - The Journal of …, 2013 - academic.oup.com
Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …

Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls

SF Witchel, SE Oberfield, AS Peña - Journal of the Endocrine …, 2019 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by
hyperandrogenism and chronic anovulation. Depending on diagnostic criteria, 6% to 20% of …

[HTML][HTML] Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop …

BCJM Fauser, BC Tarlatzis, RW Rebar, RS Legro… - Fertility and sterility, 2012 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with
a high prevalence. The etiology of this heterogeneous condition remains obscure, and its …

Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome

DA Dumesic, SE Oberfield, E Stener-Victorin… - Endocrine …, 2015 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder that has both
adverse reproductive and metabolic implications for affected women. However, there is …

Epidemiology, diagnosis, and management of polycystic ovary syndrome

SM Sirmans, KA Pate - Clinical epidemiology, 2013 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common heterogeneous endocrine disorder
characterized by irregular menses, hyperandrogenism, and polycystic ovaries. The …

[HTML][HTML] Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

MA Sanchez-Garrido, M Tena-Sempere - Molecular metabolism, 2020 - Elsevier
Background Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among
reproductive age women. Although its cardinal manifestations include hyperandrogenism …